arrow_back Back to App

APOL1-Mediated Kidney Disease Awareness Day Support

The House of Representatives supports designating the last Tuesday of April as APOL1-Mediated Kidney Disease (AMKD) Awareness Day. This aims to boost public understanding of AMKD, especially for individuals of African descent who face higher risks. Citizens are encouraged to consider genetic testing and adopt healthy lifestyles to prevent disease progression.
Key points
Designation of AMKD Awareness Day seeks to educate the public about kidney disease, particularly those linked to the APOL1 gene.
Individuals of West and Central African ancestry are encouraged to consider genetic testing for APOL1 gene mutations, aiding early risk detection.
Emphasis is placed on regular doctor visits, healthy diet, exercise, and avoiding smoking to reduce kidney failure risk for those with APOL1 gene variants.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HRES_360
Sponsor: Del. Plaskett, Stacey E. [D-VI-At Large]
Process start date: 2025-04-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HRES_360.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-29.

What are the main provisions?

Key points include:

  • Designation of AMKD Awareness Day seeks to educate the public about kidney disease, particularly those linked to the APOL1 gene.
  • Individuals of West and Central African ancestry are encouraged to consider genetic testing for APOL1 gene mutations, aiding early risk detection.
  • Emphasis is placed on regular doctor visits, healthy diet, exercise, and avoiding smoking to reduce kidney failure risk for those with APOL1 gene variants.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Del. Plaskett, Stacey E. [D-VI-At Large].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-21.

CATEGORIES

Health